UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 26, 2021
Accession Number:
0001437749-21-007169
Submission Type:
POS AM
CIK:
0001742927
Company Name:
REVIVA PHARMACEUTICALS HOLDINGS, INC.
File Number:
333-251802